Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Net Income: 2015-2025

Historic Net Income for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to -$19.8 million.

  • AC Immune's Net Income fell 412.11% to -$19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.1 million, marking a year-over-year decrease of 92.76%. This contributed to the annual value of -$58.1 million for FY2024, which is 4.94% up from last year.
  • Latest data reveals that AC Immune reported Net Income of -$19.8 million as of Q3 2025, which was up 27.94% from -$27.5 million recorded in Q2 2025.
  • AC Immune's Net Income's 5-year high stood at $6.4 million during Q3 2024, with a 5-year trough of -$28.4 million in Q4 2021.
  • Its 3-year average for Net Income is -$16.9 million, with a median of -$18.7 million in 2023.
  • Per our database at Business Quant, AC Immune's Net Income spiked by 137.06% in 2024 and then plummeted by 412.11% in 2025.
  • Quarterly analysis of 5 years shows AC Immune's Net Income stood at -$28.4 million in 2021, then skyrocketed by 31.50% to -$19.5 million in 2022, then soared by 72.45% to -$5.4 million in 2023, then tumbled by 235.84% to -$18.0 million in 2024, then tumbled by 412.11% to -$19.8 million in 2025.
  • Its last three reported values are -$19.8 million in Q3 2025, -$27.5 million for Q2 2025, and -$20.8 million during Q1 2025.